» Articles » PMID: 18406327

Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2008 Apr 15
PMID 18406327
Citations 213
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylases (HDACs) are enzymes that modify key residues in histones to regulate chromatin architecture, and they play a vital role in cell survival, cell-cycle progression, and tumorigenesis. To understand the function of Hdac3, a critical component of the N-CoR/SMRT repression complex, a conditional allele of Hdac3 was engineered. Cre-recombinase-mediated inactivation of Hdac3 led to a delay in cell-cycle progression, cell-cycle-dependent DNA damage, and apoptosis in mouse embryonic fibroblasts (MEFs). While no overt defects in mitosis were observed in Hdac3-/- MEFs, including normal H3Ser10 phosphorylation, DNA damage was observed in Hdac3-/- interphase cells, which appears to be associated with defective DNA double-strand break repair. Moreover, we noted that Hdac3-/- MEFs were protected from DNA damage when quiescent, which may provide a mechanistic basis for the action of HDAC inhibitors on cycling tumor cells.

Citing Articles

HDAC Inhibitors Can Enhance Radiosensitivity of Head and Neck Cancer Cells Through Suppressing DNA Repair.

Antrobus J, Mackinnon B, Melia E, Hughes J, Parsons J Cancers (Basel). 2024; 16(23).

PMID: 39682293 PMC: 11640432. DOI: 10.3390/cancers16234108.


Multi-Target Inhibitor CUDC-101 Impairs DNA Damage Repair and Enhances Radiation Response in Triple-Negative Breast Cell Line.

Seane E, Nair S, Vandevoorde C, Bisio A, Joubert A Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598379 PMC: 11597529. DOI: 10.3390/ph17111467.


Hdac3 deficiency limits periosteal reaction associated with Western diet feeding in female mice.

Vu E, Karkache I, Pham A, Koroth J, Bradley E J Cell Mol Med. 2024; 28(17):e70081.

PMID: 39261913 PMC: 11390340. DOI: 10.1111/jcmm.70081.


HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

Cassandri M, Porrazzo A, Pomella S, Noce B, Zwergel C, Aiello F Cell Death Discov. 2024; 10(1):351.

PMID: 39107280 PMC: 11303816. DOI: 10.1038/s41420-024-02115-y.


The role of HDAC3 in inflammation: mechanisms and therapeutic implications.

Watson N, Kuppuswamy S, Ledford W, Sukumari-Ramesh S Front Immunol. 2024; 15:1419685.

PMID: 39050859 PMC: 11266039. DOI: 10.3389/fimmu.2024.1419685.


References
1.
Prasanth S, Prasanth K, Siddiqui K, Spector D, Stillman B . Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J. 2004; 23(13):2651-63. PMC: 449767. DOI: 10.1038/sj.emboj.7600255. View

2.
Wang J, Hoshino T, Redner R, Kajigaya S, Liu J . ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A. 1998; 95(18):10860-5. PMC: 27986. DOI: 10.1073/pnas.95.18.10860. View

3.
Strom D, Nip J, Westendorf J, Linggi B, Lutterbach B, Downing J . Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. J Biol Chem. 2000; 275(5):3438-45. DOI: 10.1074/jbc.275.5.3438. View

4.
Fernandez-Capetillo O, Nussenzweig A . Linking histone deacetylation with the repair of DNA breaks. Proc Natl Acad Sci U S A. 2004; 101(6):1427-8. PMC: 341727. DOI: 10.1073/pnas.0307342101. View

5.
Bartova E, Pachernik J, Harnicarova A, Kovarik A, Kovarikova M, Hofmanova J . Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. J Cell Sci. 2005; 118(Pt 21):5035-46. DOI: 10.1242/jcs.02621. View